Vasopressin: a novel target for the prevention and retardation of kidney disease?
about
A review of the nonpressor and nonantidiuretic actions of the hormone vasopressinFructokinase activity mediates dehydration-induced renal injuryInhibition of ENaC by endothelin-1Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and ureaCopeptin and Decline in Kidney FunctionPathophysiology of copeptin in kidney disease and hypertensionPredictors of autosomal dominant polycystic kidney disease progressionUrine osmolarity and risk of dialysis initiation in a chronic kidney disease cohort--a possible titration target?Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.Coordinated Regulation of Vasopressin Inactivation and Glucose Uptake by Action of TUG Protein in Muscle.Assessment of carboprost tromethamine for reducing hemorrhage in laparoscopic intramural myomectomy.Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress NephropathyDiabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study.Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.AKAP220 manages apical actin networks that coordinate aquaporin-2 location and renal water reabsorption.Chronic recurrent dehydration associated with periodic water intake exacerbates hypertension and promotes renal damage in male spontaneously hypertensive rats.Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.Vasopressin regulation of sodium transport in the distal nephron and collecting duct.Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.Rehydration with soft drink-like beverages exacerbates dehydration and worsens dehydration-associated renal injury.Effects of exogenous desmopressin on a model of heat stress nephropathy in mice.Regulation of renal Na-(K)-Cl cotransporters by vasopressin.Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 TrialThe vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.Increased levels of copeptin before clinical diagnosis of preelcampsia.Hydration and kidney health.Hypothalamic-Pituitary-Adrenal Axis Modulation of Glucocorticoids in the Cardiovascular System.The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels.PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.Vasopressin: physiology, assessment and osmosensation.Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.Validation of Surrogates of Urine Osmolality in Population Studies.Hyperosmolarity drives hypertension and CKD--water and salt revisited.Association of a Low-Protein Diet With Slower Progression of CKD.Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank.Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.
P2860
Q21131156-AB462F28-1CC7-4107-BA5F-DF2D7E9138E3Q24561578-96DE825E-FEDE-4366-AE21-8AE6BE6E4A74Q27005957-EFB06916-D1AE-486C-AFE6-AAE2100B5271Q28085593-DA5031F6-0AB5-4082-8D60-44F4A7B01988Q33613314-DFE794F6-7180-41AF-BA81-499ED510C1E0Q33792317-08D5EE12-6069-4C24-B7E0-399A944F04BFQ34427678-C549B963-CC6F-41D5-9724-06E243B566A3Q35133545-88B77B41-347A-4CCD-814C-AB1E7D5F8338Q35658585-7FA49C7D-2800-43DD-B513-820D14617E7CQ35860779-FA01183E-97EC-4705-B714-7A4D04B466BBQ35942689-BEDA312E-950C-4396-921F-72158433B6E1Q36010406-6BD4241A-1E4A-41D0-BB54-E0349B1B2ED9Q36095944-8B10C447-C407-44C5-9419-4FD474C3C36BQ36247486-97100650-12AE-4331-BC60-36CC5EA3F01CQ36329310-EAEF6AF4-9709-4719-8F5F-242C5DC4A3F6Q37142710-F71FCAAA-421C-4109-97EF-8762D1386729Q37274293-08A0BC55-CB21-4511-93BC-E56E271274BDQ37278044-9EC7F044-1372-49EA-B1FD-7DF287672C87Q37633162-3DB3FB55-8658-4CA9-8E70-DAB64C574811Q38515104-BE0FB467-63CA-452A-ACBC-789B13602AADQ38737946-BBFA4E0B-9392-4532-B146-C986AD896C8DQ38853071-C56C3C91-43A6-48B9-AD4C-45A00831CD08Q39017490-4D8AE9A2-22A2-4505-9D09-48648D27CEE3Q39076966-C08933E9-950B-401D-9885-B9B7A6DD7C0FQ39347476-21B5AF44-3081-4473-B42C-AE7988F287CFQ41076909-88E10F10-B1CB-4B32-A14E-4F27DE6C3A6FQ41998074-EE396A3A-2614-4FEA-A0A4-F67CA18D09C9Q45002550-FAA351B3-12E5-4D09-BC96-9DC1A4760BCAQ45233930-A5FED24A-8200-40FF-91C8-E2E2F737365FQ45351708-46FCF2A1-D941-483B-8A0D-97BE9F3D3AB7Q47104362-781A99D9-F1C0-4A91-9E77-8822FF1BE017Q47291983-8DC36BFA-A1D3-44E0-ACE3-8FAD578FDD2EQ47334957-4176295A-43DA-4528-B476-40DD85C5C4DDQ47705916-904CBD27-226B-422F-9386-01F54C953A96Q47925751-1E01C86F-EE45-44F8-8272-B7E37F27AEC1Q48015191-86618B03-A29F-4CE4-A7D5-6B7692071C7BQ48299673-F67CB440-0E66-4038-B6EB-14E826C97D2AQ49197177-8E1B1699-110C-4855-A51C-1DE590EA5CA7Q50300651-367D6964-A84E-4BA8-B7A5-94DACF5A503FQ51308854-88185085-AD58-4B14-98B0-768E97B720A3
P2860
Vasopressin: a novel target for the prevention and retardation of kidney disease?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vasopressin: a novel target for the prevention and retardation of kidney disease?
@en
type
label
Vasopressin: a novel target for the prevention and retardation of kidney disease?
@en
prefLabel
Vasopressin: a novel target for the prevention and retardation of kidney disease?
@en
P2860
P356
P1476
Vasopressin: a novel target for the prevention and retardation of kidney disease?
@en
P2093
Eberhard Ritz
Nadine Bouby
P2860
P2888
P304
P356
10.1038/NRNEPH.2013.22
P407
P50
P577
2013-02-26T00:00:00Z